Free Trial
NYSEAMERICAN:CRHM

CRH Medical (CRHM) Stock Price, News & Analysis

CRH Medical logo
$3.99 0.00 (0.00%)
(As of 04/22/2021)

About CRH Medical Stock (NYSEAMERICAN:CRHM)

Key Stats

Today's Range
$3.99
$4.00
50-Day Range
N/A
52-Week Range
$1.66
$4.01
Volume
388,400 shs
Average Volume
1.04 million shs
Market Capitalization
$285.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CRH Medical Corporation provides anesthesia services for patients undergoing endoscopic procedures in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology to treat various grades of hemorrhoid. The company also distributes CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to physicians. It serves 70 ambulatory surgical/endoscopy centers in 14 states. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was founded in 2000 and is headquartered in Vancouver, Canada.

Receive CRHM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CRH Medical and its competitors with MarketBeat's FREE daily newsletter.

CRHM Stock News Headlines

CRH plc (CRH) Q2 2024 Earnings Call Transcript
Has Trump Finally Gone Too Far?
Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.
CRH PLC American Depositary Shares (CRH)
CRH Medical Corp (CRHM)
See More Headlines

CRHM Stock Analysis - Frequently Asked Questions

CRH Medical Co. (NYSEAMERICAN:CRHM) announced its quarterly earnings results on Thursday, November, 12th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.01). The company had revenue of $30.35 million for the quarter, compared to the consensus estimate of $29.50 million. CRH Medical had a negative net margin of 4.12% and a negative trailing twelve-month return on equity of 3.37%.

Shares of CRHM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that CRH Medical investors own include CRH Medical (CRH), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), AcelRx Pharmaceuticals (ACRX), Ampio Pharmaceuticals (AMPE), Extreme Networks (EXTR) and Palatin Technologies (PTN).

Company Calendar

Last Earnings
11/12/2020
Today
12/21/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Health Services
Sub-Industry
Healthcare
Current Symbol
NYSEAMERICAN:CRHM
Previous Symbol
NYSEARCA:CRHM
CIK
N/A
Fax
N/A
Employees
133
Year Founded
N/A

Profitability

Net Income
$3.77 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$120.39 million
Cash Flow
$0.99 per share
Book Value
$1.73 per share

Miscellaneous

Free Float
N/A
Market Cap
$285.76 million
Optionable
Not Optionable
Beta
2.41
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report

This page (NYSEAMERICAN:CRHM) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners